BioCryst director granted 644 shares at $9.70
Biocryst director Jon P. Stonehouse received a small stock grant in lieu of part of his quarterly cash board retainer.
Rhea-AI Filing Summary
BIOCRYST PHARMACEUTICALS INC (symbol: BCRX) is the issuer of record for a Form 4 filing submitted to the SEC. Stonehouse Jon P reported acquisition or exercise transactions in this Form 4 filing.
BIOCRYST PHARMACEUTICALS INC (BCRX) director Jon P. Stonehouse received a grant of 644 shares of Common Stock on August 31, 2026, at a value of $9.70 per share. The shares were issued in lieu of 50% of a quarterly cash Board Member retainer of $12,500. Following this award, he holds 1,340,419 shares directly, plus 40,000 shares held indirectly in each of two irrevocable trusts for Caroline and Samuel Stonehouse. No Rule 10b5‑1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 644 shares
Grant/Award
3 txns
Insider
Stonehouse Jon P
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 644 | $9.70 | $6K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,340,419 shares (Direct);
Common Stock — 40,000 shares (Indirect, By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust);
Common Stock — 40,000 shares (Indirect, By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust)
Footnotes (1)
- F1. Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $12,500.
Key Figures
Shares granted: 644 shares
Grant value per share: $9.70 per share
Quarterly Board Member retainer: $12,500
+3 more
6 metrics
Shares granted
644 shares
Equity issued on August 31, 2026 in lieu of part of quarterly Board retainer
Grant value per share
$9.70 per share
Value used for the 644-share Common Stock grant on August 31, 2026
Quarterly Board Member retainer
$12,500
Shares issued in lieu of 50% of this quarterly cash Board Member retainer
Direct holdings after grant
1,340,419 shares
Jon P. Stonehouse direct Common Stock ownership after August 31, 2026 grant
Indirect holdings – Caroline trust
40,000 shares
Common Stock held indirectly by wife as co‑trustee of the Caroline Stonehouse Irrevocable Trust
Indirect holdings – Samuel trust
40,000 shares
Common Stock held indirectly by wife as co‑trustee of the Samuel Stonehouse Irrevocable Trust
Key Terms
Irrevocable Trust, co-trustee, quarterly cash Board Member retainer
3 terms
Irrevocable Trust financial
"By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
co-trustee financial
"By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust"
quarterly cash Board Member retainer financial
"in lieu of 50% of the quarterly cash Board Member retainer of $12,500"
FAQ
What did BCRX director Jon P. Stonehouse report on this Form 4?
He reported a grant of 644 shares of Common Stock on August 31, 2026. The shares were issued in lieu of 50% of a $12,500 quarterly cash Board Member retainer, representing equity compensation rather than cash for part of his director fees.
What indirect BCRX holdings are associated with Jon P. Stonehouse?
There are two indirect positions of 40,000 BCRX shares each, held by his wife as co‑trustee of the Caroline Stonehouse Irrevocable Trust and the Samuel Stonehouse Irrevocable Trust. These are reported as indirect beneficial ownership.
Was Jon P. Stonehouse’s BCRX transaction under a Rule 10b5-1 plan?
No. The filing indicates no Rule 10b5-1 trading plan; the document-level checkbox affirming trades under such a plan is not selected for these reported holdings and the 644-share grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
